Cincinnati, Ohio 45213

  • Migraine Disorders

Purpose:

The objective of this trial is to test whether an online tailored intervention, Migraine Manager, is efficacious in improving headache outcomes compared to an attention control intervention in adolescents with migraines. We will conduct a randomized clinical trial to compare a sample of 80 youth (ages 11 to 17) with migraine receiving the online tailored adherence intervention to 80 youth in an attention control group. We will test whether adherence to healthy habit (hydration, regular meals, exercise, sleep) recommendations serves as a mechanism for improved headache outcomes. Clinically meaningful outcomes will be assessed by reliable, valid, and sensitive measures. The primary outcome (i.e., number of headache days) will be assessed via online daily diary pre- and post-intervention, with additional follow-up at 3, 6, 9, and 12 months. Secondary outcomes include health-related quality of life and migraine disability.


Criteria:

Inclusion Criteria: - Confirmed diagnosis of migraine using current International Classification of Headache Disorders Criteria (ICHD-3) for migraine with or without aura - Frequency of 8 or more headaches per month - Access to the internet whether public (e.g., library) or private (e.g., home, personal) - English fluency for patient and caregiver Exclusion Criteria: - Patients with a diagnosis of pervasive developmental disorder as determined by medical chart review - Patients with a diagnosis of or serious mental illness (e.g., psychotic disorder) as determined by medical chart review


NCT ID:

NCT04567355


Primary Contact:

Principal Investigator
Kevin Hommel, PhD
Children's Hospital Medical Center, Cincinnati

Kevin Hommel, PhD
Phone: 513-803-0407
Email: kevin.hommel@cchmc.org


Backup Contact:

Email: jessica.king1@cchmc.org
Jessica King, BA
Phone: 513-803-0920


Location Contact:

Cincinnati, Ohio 45213
United States

Kevin Hommel, PhD
Phone: 513-803-0407
Email: kevin.hommel@cchmc.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 02, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.